Standard Biotools LAB Income Statement (2010-2026)

NASDAQ LAB
$0.72 +0.02 (+3.60%)
As of: Sep 9, 2026 · 1:40 PM EDT
Reported Financials

Standard Biotools Quarterly Income Statement

Periods 65 quarters
Latest Jun 2026

Standard Biotools reported revenue of $20.10M and net income of -$26.76M for the quarter ended Jun 2026, down 7.6% year over year. This income statement covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
92.32M26.50M18.78M25.65M27.02M25.12M27.67M25.37M28.19M45.54M22.49M22.09M24.78M20.22M21.76M19.55M23.80M21.15M20.10M
Cost of RevenueCost of Rev
37.72M12.34M14.35M16.43M15.85M12.84M14.06M14.21M14.83M21.35M12.12M9.96M13.42M9.17M11.13M10.07M12.41M9.84M9.57M
Gross Profit
54.60M14.16M4.43M9.22M11.17M12.28M13.60M11.15M13.36M24.19M10.37M12.13M11.36M11.05M10.63M9.48M11.38M11.31M10.54M
Operating items
Research & DevelopmentR&D
29.40M8.87M12.61M8.49M7.42M6.43M6.18M6.37M6.91M15.98M7.24M6.94M7.04M5.44M6.22M6.36M7.97M2.12M1.98M
Selling, General & AdministrativeSG&A
75.93M30.88M30.08M26.34M20.22M21.30M22.60M22.29M21.35M46.94M24.86M24.47M27.32M29.82M28.11M26.59M25.34M18.61M16.39M
Restructuring CostsRestructuring
0.30M3.41M4.63M1.20M2.30M2.00M1.69M17.16M5.75M5.08M2.96M1.55M1.73M9.43M2.08M3.08M14.75M
Other Operating ExpensesOther Opex
43.19M14.27M0.01M-0.05M-0.03M1.66M4.79M4.28M2.78M2.34M0.13M1.20M0.27M0.04M0.65M2.81M
Operating ExpensesOpex
148.52M54.01M42.99M38.25M32.28M28.87M31.05M32.33M34.74M84.37M40.63M38.83M37.44M38.02M36.33M42.42M36.03M23.80M35.92M
Operating IncomeOp. Inc
-56.20M-27.50M-38.56M-29.03M-21.11M-16.59M-17.45M-21.17M-21.39M-60.18M-30.26M-26.70M-26.08M-26.97M-25.70M-32.94M-24.64M-12.50M-25.39M
EBIT
-56.20M-27.50M-38.56M-29.03M-21.11M-16.59M-17.45M-21.17M-21.39M-60.18M-30.26M-26.70M-26.08M-26.97M-25.70M-32.94M-24.64M-12.50M-25.39M
Non-operating items
Non Operating Interest Expenses
2.75M1.03M1.06M1.05M1.19M0.06M1.13M1.22M1.10M2.23M
Non Operating Investment IncomeNon-Op. Investment Inc.
Other Non Operating IncomeOther Non Op Inc.
0.53M0.12M-0.17M-0.06M-0.70M1.13M0.47M-0.12M1.10M25.21M0.41M0.96M0.57M4.96M-2.09M0.96M-5.63M-0.66M
Net income details
EBT
-53.42M-76.86M-65.15M-30.14M-20.77M-16.58M-16.74M-20.95M-19.94M-32.03M-25.41M-21.80M-26.90M-23.49M-18.28M-32.90M-22.03M-14.62M-21.43M
Tax ProvisionsTaxes
-3.61M-0.60M-1.61M-0.71M0.07M0.30M0.30M0.10M-16.20M0.13M0.04M0.12M-19.28M-0.12M-0.61M-1.22M-35.93M0.01M0.10M
Profit After TaxPAT
-49.81M-76.29M-63.54M-29.43M-20.84M-16.84M-17.04M-41.20M34.34M-32.16M-45.72M-26.94M-29.11M-26.03M-33.46M-34.69M19.28M127.07M-26.76M
Income from Continuing OperationsIncome (Continuing)
-49.81M-76.26M-63.54M-29.43M-20.84M-16.88M-17.04M-21.05M-3.74M-32.16M-25.44M-21.92M-7.62M-23.37M-17.67M-31.68M13.90M-14.63M-21.54M
Income from Discontinued OperationsIncome (Discontinued)
-20.27M-5.02M-6.90M-2.66M-15.79M-3.00M5.38M141.69M-5.23M
Consolidated Net IncomeConsol Net Inc.
-49.81M-76.26M-63.54M-29.43M-20.84M-16.88M-17.04M-21.05M-3.74M-32.16M-45.72M-26.94M-14.52M-26.03M-33.46M-34.69M19.28M127.07M-26.77M
Income towards Parent CompanyParent Net Inc
-49.81M-76.26M-63.54M-29.43M-20.84M-16.88M-17.04M-21.05M-3.74M-32.16M-25.44M-21.92M-27.17M-26.03M-17.67M-31.68M13.90M127.07M-26.77M
Preferred Dividend PaymentsPref Dividends
Net Income towards Common StockholdersNet Income
-49.81M-76.26M-63.54M-29.43M-20.84M-16.88M-17.04M-21.05M-3.74M-32.16M-45.72M-26.94M-34.07M-26.03M-33.46M-34.69M19.28M127.07M-26.77M
Additional items
EPS (Basic)
-0.65-0.99-0.82-0.37-0.27-0.21-0.22-0.27-0.05-0.11-0.12-0.07-0.10-0.07-0.09-0.090.050.33-0.07
EPS (Diluted)
-0.65-0.99-0.82-0.37-0.27-0.21-0.22-0.27-0.05-0.11-0.12-0.07-0.10-0.07-0.09-0.090.050.33-0.07
Shares Outstanding
76.30M75.79M77.03M77.82M78.90M78.31M79.08M78.67M79.15M79.16M294.12M372.33M371.54M353.25M378.23M380.50M382.63M381.62M388.20M390.88M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
76.30M75.79M77.03M77.82M78.90M78.31M79.08M78.67M79.15M79.16M294.12M372.33M371.54M353.25M378.23M380.50M382.63M381.62M388.20M390.88M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
76.48M76.92M77.20M78.65M79.25M79.48M78.65M79.12M79.47M80.23M294.12M371.12M372.26M377.53M379.09M381.69M383.61M386.38M390.14M392.12M
EBITDA
-56.20M-27.50M-38.56M-29.03M-21.11M-16.59M-17.45M-21.17M-21.39M-60.18M-30.26M-26.70M-26.08M-26.97M-25.70M-32.94M-24.64M-12.50M-25.39M
Interest ExpensesInt Expense
2.75M1.03M1.06M1.05M1.19M0.06M1.13M1.22M1.10M1.03M0.86M0.85M0.57M0.00M0.01M0.01M0.01M
Tax Rate
6.76%0.78%2.48%2.37%-0.34%-1.81%-1.80%-0.48%81.24%-0.40%-0.15%-0.54%71.68%0.51%3.33%3.70%163.10%-0.08%-0.47%